|

Ademetionine 1,4-Butanedisulfonate Clinical Trials

2 actively recruiting trials

Also known as: Transmeti

Pipeline

Phase 2: 1

Top Sponsors

  • General Hospital of Shenyang Military Region1
  • China National Center for Cardiovascular Diseases1

Indications

  • Drug Induced Liver Injury1
  • Obstructive Hypertrophic Cardiomyopathy (oHCM)1
  • Liver Disease1
  • Heart Disease1

Other2 trials

Ademetionine in Obstructive Hypertrophic Cardiomyopathy
Phase 2
Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.